1-11 of 11
David S. Alberts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer

Setsuko K. Chambers, H-H. Sherry Chow, Mike F. Janicek, Janiel M. Cragun, Kenneth D. Hatch, Haiyan Cui, Cynthia Laughren, Mary C. Clouser, Janice L. Cohen, Heather M. Wright, Nisreen Abu Shahin, David S. Alberts
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2668–2678.
https://doi.org/10.1158/1078-0432.CCR-12-0261
Published: 30 April 2012
View article titled, Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer
Open the PDF for Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer in another window
Journal Articles

Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer

Setsuko K. Chambers, Mary C. Clouser, Amanda F. Baker, Denise J. Roe, Haiyan Cui, Molly A. Brewer, Kenneth D. Hatch, Michael S. Gordon, Mike F. Janicek, Jeffrey D. Isaacs, Alan N. Gordon, Raymond B. Nagle, Heather M. Wright, Janice L. Cohen, David S. Alberts
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5320–5328.
https://doi.org/10.1158/1078-0432.CCR-10-0974
Published: 31 October 2010
View article titled, Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer
Open the PDF for Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer in another window
Journal Articles

Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

H-H. Sherry Chow, Iman A. Hakim, Donna R. Vining, James A. Crowell, James Ranger-Moore, Wade M. Chew, Catherine A. Celaya, Steven R. Rodney, Yukihiko Hara, David S. Alberts
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4627–4633.
https://doi.org/10.1158/1078-0432.CCR-04-2549
Published: 15 June 2005
View article titled, Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals
Open the PDF for Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals in another window
Journal Articles

Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs

Gary J. Kelloff, Richard L. Schilsky, David S. Alberts, Robert W. Day, Kathryn Z. Guyton, Homer L. Pearce, Jonathan C. Peck, Robert Phillips, Caroline C. Sigman
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3908–3918.
https://doi.org/10.1158/1078-0432.CCR-03-0789
Published: 01 June 2004
View article titled, Colorectal Adenomas: <subtitle>A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs</subtitle>
Open the PDF for Colorectal Adenomas: <subtitle>A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs</subtitle> in another window
Journal Articles

Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients

Goli Samimi, Nissi M. Varki, Sharon Wilczynski, Roohangiz Safaei, David S. Alberts, Stephen B. Howell
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5853–5859.
Published: 15 December 2003
View article titled, Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients
Open the PDF for Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients in another window
Journal Articles

Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals

H-H. Sherry Chow, Yan Cai, Iman A. Hakim, James A. Crowell, Farah Shahi, Chris A. Brooks, Robert T. Dorr, Yukihiko Hara, David S. Alberts
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3312–3319.
Published: 05 September 2003
View article titled, Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals
Open the PDF for Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals in another window
Journal Articles

Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis

John L. Clifford, Eugene Walch, Xiulan Yang, Xiaochun Xu, David S. Alberts, Gary L. Clayman, Adel K. El-Naggar, Reuben Lotan, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2067–2072.
Published: 01 July 2002
View article titled, Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis
Open the PDF for Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis in another window
Journal Articles

Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

Joyce A. O’Shaughnessy, Gary J. Kelloff, Gary B. Gordon, Andrew J. Dannenberg, Waun Ki Hong, Carol J. Fabian, Caroline C. Sigman, Monica M. Bertagnolli, Steven P. Stratton, Stephen Lam, William G. Nelson, Frank L. Meyskens, David S. Alberts, Michele Follen, Anil K. Rustgi, Vali Papadimitrakopoulou, Peter T. Scardino, Adi F. Gazdar, Lee W. Wattenberg, Michael B. Sporn, Wael A. Sakr, Scott M. Lippman, Daniel D. Von Hoff
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (2): 314–346.
Published: 01 February 2002
View article titled, Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : <subtitle>Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia</subtitle>
Open the PDF for Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : <subtitle>Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia</subtitle> in another window
Journal Articles

Modulation of Biologic Endpoints by Topical Difluoromethylornithine (DFMO), in Subjects at High-Risk for Nonmelanoma Skin Cancer

Janine G. Einspahr, Mark A. Nelson, Kathylynn Saboda, James Warneke, G. Timothy Bowden, David S. Alberts
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (1): 149–155.
Published: 01 January 2002
View article titled, Modulation of Biologic Endpoints by Topical Difluoromethylornithine (DFMO), in Subjects at High-Risk for Nonmelanoma Skin Cancer
Open the PDF for Modulation of Biologic Endpoints by Topical Difluoromethylornithine (DFMO), in Subjects at High-Risk for Nonmelanoma Skin Cancer in another window
Journal Articles

Phase I Pharmacokinetic Trial and Correlative in Vitro Phase II Tumor Kinetic Study of Apomine (SR-45023A), a Novel Oral Biphosphonate Anticancer Drug

David S. Alberts, Alton V. Hallum III, Mary Stratton-Custis, Dava J. Garcia, Mary Gleason-Guzman, Sydney E. Salmon, Pedro Santabarbara, Eric J. Niesor, Simon Floret, Craig L. Bentzen
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1246–1250.
Published: 01 May 2001
View article titled, Phase I Pharmacokinetic Trial and Correlative <em>in Vitro</em> Phase II Tumor Kinetic Study of Apomine (SR-45023A), a Novel Oral Biphosphonate Anticancer Drug
Open the PDF for Phase I Pharmacokinetic Trial and Correlative <em>in Vitro</em> Phase II Tumor Kinetic Study of Apomine (SR-45023A), a Novel Oral Biphosphonate Anticancer Drug in another window
Journal Articles

Analysis of MLH1 and MSH2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy

Goli Samimi, Daniel Fink, Nissi M. Varki, Amreen Husain, William J. Hoskins, David S. Alberts, Stephen B. Howell
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (4): 1415–1421.
Published: 01 April 2000
View article titled, Analysis of MLH1 and MSH2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy
Open the PDF for Analysis of MLH1 and MSH2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy in another window